Human and Mouse IFN-β Gene Therapy Exhibits Different Anti-tumor Mechanisms in Mouse Models
Open Access
- 1 October 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (4) , 356-364
- https://doi.org/10.1006/mthe.2001.0464
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Interferon-β is required for interferon-α production in mouse fibroblastsCurrent Biology, 1998
- Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor modelsGene Therapy, 1997
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsThe Journal of Experimental Medicine, 1997
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Interferon-β in Healthy Male VolunteersJournal of Interferon & Cytokine Research, 1996
- The neglected role of type I interferon in the T-cell response: implications for its clinical useImmunology Today, 1996
- Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in VivoScience, 1996
- IFN‐α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 miceInternational Journal of Cancer, 1995
- The human interferon α-receptor protein confers differential responses to human interferon-β versus interferon-α subtypes in mouse and hamster cell transfectantsCytokine, 1994
- Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in MiceJNCI Journal of the National Cancer Institute, 1989
- Mouse Interferon Receptors: A Difference in Their Response to and beta InterferonsJournal of General Virology, 1983